Join Our Mailing List
Please CLICK HERE to download a brochure for this event.
The full speaker list for this conference has not yet been announced. Please check back in the coming weeks for further information.
Charles Bernick, MD, Associate Medical Director, Lou Ruvo Center for Brain Health, Cleveland Clinic
Mikael Brönnegård, MD., Ph.D., Associate Professor, Karolinska Institute, Chief Executive Officer, NeuroVive Pharmaceutical AB
Stuart Blincko, Ph.D., Sr. Principal Research Scientist, Abbott Diagnostics
Peter Como, Ph.D. (tentative), Lead Reviewer, Neuropsychologist, Division of Ophthalmic, Neurological & Ear, Nose & Throat Devices (DONED), Neurodiagnostic and Neurotherapeutic Devices Branch (NNDB), US Food & Drug Administration
Nicholas Conti, Ph.D., Vice President, Business Development, Quest Diagnostics
Ralph G DePalma, MD, FACS, Special Operations Officer, VA Office of Research & Development, Professor of Surgery, Uniformed Services University of the Health Sciences
Ramon Diaz-Arrastia, MD, Ph.D., Professor of Neurology, Uniformed Services University of the Health Sciences, Director of Clinical Research, Center for Neuroscience & Regenerative Medicine
Alan Faden, MD, David S. Brown Professor in Trauma, Professor, Departments of Anesthesiology, Anatomy & Neurobiology, Neurosurgery, and Neurology, Director, Center for Shock, Trauma & Anesthesiology Research (STAR), University of Maryland School of Medicine
Sam Gandy, MD, Ph.D., Professor of Neurology and Psychiatry (Dual Primary Appointments), Mount Sinai Chair in Alzheimer’s Disease Research, Director, Mount Sinai Center for Cognitive Health and NFL Neurological Care, Associate Director, Mount Sinai Alzheimer’s Disease Research Center, Mount Sinai School of Medicine and James J Peters VA Medical Center
Joshua Gatson, Ph.D., Assistant Professor, Division of Burn/Trauma/Critical Care, Department of Surgery, UT Southwestern Medical Center
Larry Glass, CEO, Neuren Pharmaceuticals
Ronald L. Hayes, Ph.D., Founder & President, Banyan Biomarkers
Kim A. Heidenreich, Ph.D., Professor, Department of Pharmacology, Neuroscience Program, University of Colorado School of Medicine, Anschutz Medical Center
Graham Hubler, Ph.D., Director, Sydney Kimmel Institute for Nuclear Renaissance (SKINR), Department of Physics and Astronomy, University of Missouri
Andreas Jeromin, Ph.D., Chief Scientific Officer, NextGen Sciences
Andrew Maas, MD, Ph.D., Professor & Chairman, Department of Neurosurgery, University Hospital Antwerp
Thomas W. MacAllister, JD, Ph.D., President & Chief Executive Officer, BHR Pharma, LLC
Geoffrey T. Manley, MD, Ph.D., Professor and Vice Chairman of Neurological Surgery, University of California, San Francisco, Chief of Neurosurgery, San Francisco General Hospital, Co-Director, Brain and Spinal Injury Center (BASIC)
Andrew Mayer, Ph.D., Associate Professor of Translational Neuroscience, The Mind Research Network, Adjunct Assistant Professor of Neurology and Psychology, University of New Mexico
Guy Miller, MD, Ph.D., Chairman and Chief Executive Officer, Edison Pharmaceuticals, Inc.
Mark Mintun, MD, Chief Medical Officer, Avid Radiopharmaceuticals (Eli Lilly & Co.)
Gregory P. Mueller, Ph.D., Professor, Vice Chair for Research, Uniformed Services University of the Health Sciences
Giulio Maria Pasinetti, MD, Ph.D., Professor of Psychiatry, Neuroscience, Geriatrics and Adult Development, Department of Psychiatry, Mount Sinai School of Medicine
Daniel Perl, MD, Professor of Pathology (Neuropathology), Uniformed Services University of the Health Sciences
Paul Rapp, Ph.D., Professor of Military and Emergency Medicine, Uniformed Services University, Director, Traumatic Injury Research Program
Roger Sabbadini, Ph.D., Vice President & Founder, Lpath, Inc.
Deborah A. Shear, Ph.D., Neuroprotection Section Chief, Brain Trauma Neuroprotection and Neurorestoration Branch, Center for Military Psychiatry and Neuroscience (CMPN), Walter Reed Army Institute of Research
Martha Shenton, Ph.D., Professor and Director, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School
Adam J. Simon, Ph.D., President & CEO, Cerora, Inc.
Robert A. Stern, Ph.D., Professor of Neurology and Neurosurgery, Center for the Study of Traumatic Encephalopathy, Director, Clinical Core, BU Alzheimer's Disease Center, Boston University School of Medicine
Frank Tegtmeier, Ph.D., Chief Scientific Officer, vasopharm
Jeff Victoroff, MD, Associate Professor Clinical Neurology & Psychiatry, University of Southern California School of Medicine